輸入代號或公司名稱後按 Enter
EOLS

Evolus, Inc.

-0.15 (-1.88%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 生技醫療 · Pharmaceutical Preparations
7.84USD432K成交股數518M市值本益比(近四季)1.6股價營收比+21.2%營收年增(近四季)2026-11-04下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營收84.1M+21%73.1M+7%90.3M+48%69.0M+3%69.4M+17%68.5M+12%61.1M+22%66.9M+36%59.3M61.0M50.0M49.3M
營業成本26.9M24.2M31.0M23.1M24.1M21.9M19.0M19.8M18.8M22.2M15.4M14.7M
毛利57.2M+26%48.9M+5%59.3M+41%45.8M-3%45.3M+12%46.7M+20%42.1M+22%47.1M+36%40.5M38.8M34.6M34.6M
毛利率68.0%66.9%65.7%66.5%65.3%68.1%68.9%70.3%68.3%63.6%69.1%70.2%
研發費用1.9M2.2M3.5M2.0M1.8M2.2M2.3M2.4M2.1M2.4M1.6M1.2M
銷售管理費用57.1M52.0M54.7M52.8M56.7M56.6M52.5M50.2M45.1M43.1M43.3M41.2M
營業利益−4.5M-56%−6.8M-55%4.2M-127%−11.5M+49%−10.2M+14%−15.2M+76%−15.5M+15%−7.7M-49%−8.9M−8.6M−13.4M−15.1M
營業利益率-5.4%-9.4%4.7%-16.7%-14.7%-22.1%-25.3%-11.5%-15.0%-14.2%-26.9%-30.6%
稅後淨利−8.1M-53%−10.7M-43%130K-101%−15.7M+39%−17.1M+31%−18.9M+60%−19.2M+13%−11.4M-37%−13.1M−11.8M−16.9M−18.1M
淨利率-9.6%-14.6%0.1%-22.8%-24.7%-27.6%-31.4%-17.0%-22.1%-19.4%-33.8%-36.8%
稀釋 EPS-0.12-56%-0.16-47%0.01-103%-0.24+33%-0.27+23%-0.30+50%-0.300%-0.18-44%-0.22-0.20-0.30-0.32
稀釋股數65.9M65.2M64.5M64.7M64.5M63.7M63.1M62.7M58.8M56.9M57.0M56.9M

資產負債表 期末餘額

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
現金與約當現金45.2M49.8M53.8M43.5M61.7M67.9M85.0M93.7M97.0M62.8M38.7M41.7M
應收帳款62.4M52.2M54.7M50.4M47.7M47.5M44.6M43.1M34.2M30.5M30.5M29.0M
存貨40.9M24.8M27.0M32.9M26.5M10.0M14.9M13.4M11.5M11.0M17.6M19.9M
總資產248M221M226M219M229M213M230M234M226M189M168M169M
有息負債157M156M146M146M145M122M121M121M121M120M95.1M94.8M
總負債279M249M249M248M247M220M224M214M208M210M187M176M
股東權益−30.9M−28.8M−23.1M−28.8M−18.7M−6.6M5.9M19.3M18.4M−20.7M−19.4M−7.0M
負債比112.5%113.0%110.2%113.1%108.2%103.1%97.4%91.7%91.8%110.9%111.5%104.1%
淨現金(現金 − 有息負債)−112M−107M−92.3M−102M−83.7M−53.9M−36.2M−27.2M−23.7M−57.5M−56.4M−53.1M

現金流量表 單季

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營業現金流−10.0M-36%−15.6M−10.6M
資本支出415K319K256K
自由現金流−10.4M-35%−16.0M−10.9M
折舊攤銷1.5M2.3M3.9M1.1M932K1.6M1.1M1.4M1.4M1.4M1.3M1.2M
買回庫藏股
現金股利
自由現金流率-14.2%-23.3%-18.3%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2025 年度 · 297M
Reportable297M100.0%+11.6%
產品/服務2025 年度 · 297M
產品295M99.3%+11.6%
服務2.2M0.7%+12.8%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025297M+11.6%−51.6M-17.4%-0.80−45.7M
FY2024266M+31.8%−50.4M-18.9%-0.81−19.5M
FY2023202M+36.0%−61.7M-30.5%-1.08−34.5M
FY2022149M+49.1%−74.4M-50.1%-1.33−86.5M
FY202199.7M+76.3%−46.8M-47.0%-0.94−33.8M
FY202056.5M+61.9%−163M-288.3%-4.83−58.7M
FY201934.9M−90.0M-257.8%-3.19−93.7M
FY20180.00−46.9M%-1.92−25.7M